Stocks · Health care · Biological Products, (No Diagnostic Substances)

Kalaris Therapeutics, Inc.

KLRS Clue Score19
United States Fiscal year ends December CIK 0001754068 Results filed 11 Aug 2026

What the insiders did Net buying

Nothing of that kind in this period.

What was left out

Form 4 filings counted 17
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 1,586,314
History held since 31 Jul 2020